|
XNCR
|
Xencor, Inc.
|
1.33%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
1.21%
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
1.16%
|
US
|
NASDAQ
|
|
298380
|
ABL Bio Inc
|
1.01%
|
KR
|
KQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
NVTA
|
Invitae Corporation
|
0.93%
|
US
|
NYSE
|
|
011000
|
GeneOne Life Science Inc
|
0.84%
|
KR
|
KO
|
|
BNGO
|
Bionano Genomics, Inc.
|
0.83%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.76%
|
US
|
NASDAQ
|
|
INO
|
Inovio Pharmaceuticals, Inc.
|
0.76%
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
0.69%
|
US
|
NASDAQ
|
|
4142
|
Adimmune Corp
|
0.69%
|
TW
|
TW
|
|
ABUS
|
Arbutus Biopharma Corporation
|
0.68%
|
US
|
NASDAQ
|
|
AVIR
|
Atea Pharmaceuticals, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
0.66%
|
US
|
NASDAQ
|
|
OCGN
|
Ocugen, Inc.
|
0.55%
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
0.49%
|
US
|
NASDAQ
|
|
ACET
|
Adicet Bio, Inc.
|
0.47%
|
US
|
NASDAQ
|
|
MOR
|
Morphosys AG O.N.
|
0.43%
|
DE
|
XETRA
|
|
NKTX
|
Nkarta, Inc.
|
0.42%
|
US
|
NASDAQ
|